These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 33326751)

  • 1. Pulse-Chase Proteomics of the App Knockin Mouse Models of Alzheimer's Disease Reveals that Synaptic Dysfunction Originates in Presynaptic Terminals.
    Hark TJ; Rao NR; Castillon C; Basta T; Smukowski S; Bao H; Upadhyay A; Bomba-Warczak E; Nomura T; O'Toole ET; Morgan GP; Ali L; Saito T; Guillermier C; Saido TC; Steinhauser ML; Stowell MHB; Chapman ER; Contractor A; Savas JN
    Cell Syst; 2021 Feb; 12(2):141-158.e9. PubMed ID: 33326751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
    Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
    J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease.
    Sadleir KR; Kandalepas PC; Buggia-Prévot V; Nicholson DA; Thinakaran G; Vassar R
    Acta Neuropathol; 2016 Aug; 132(2):235-256. PubMed ID: 26993139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Aβ antibody labeling of early-onset axon terminal pathology.
    Cai Y; Zhang XM; Macklin LN; Cai H; Luo XG; Oddo S; Laferla FM; Struble RG; Rose GM; Patrylo PR; Yan XX
    Neurotox Res; 2012 Feb; 21(2):160-74. PubMed ID: 21725719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Alzheimer's β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques.
    Kandalepas PC; Sadleir KR; Eimer WA; Zhao J; Nicholson DA; Vassar R
    Acta Neuropathol; 2013 Sep; 126(3):329-52. PubMed ID: 23820808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of Abeta-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in alzheimer's disease-like transgenic mice.
    Hu L; Wong TP; Côté SL; Bell KF; Cuello AC
    Neuroscience; 2003; 121(2):421-32. PubMed ID: 14522000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-occurrence of Alzheimer's disease ß-amyloid and τ pathologies at synapses.
    Takahashi RH; Capetillo-Zarate E; Lin MT; Milner TA; Gouras GK
    Neurobiol Aging; 2010 Jul; 31(7):1145-52. PubMed ID: 18771816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse amyloid deposition, but not plaque number, is reduced in amyloid precursor protein/presenilin 1 double-transgenic mice by pathway lesions.
    van Groen T; Liu L; Ikonen S; Kadish I
    Neuroscience; 2003; 119(4):1185-97. PubMed ID: 12831872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer's mice hippocampus.
    Sanchez-Varo R; Trujillo-Estrada L; Sanchez-Mejias E; Torres M; Baglietto-Vargas D; Moreno-Gonzalez I; De Castro V; Jimenez S; Ruano D; Vizuete M; Davila JC; Garcia-Verdugo JM; Jimenez AJ; Vitorica J; Gutierrez A
    Acta Neuropathol; 2012 Jan; 123(1):53-70. PubMed ID: 22020633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics Time-Course Study of App Knock-In Mice Reveals Novel Presymptomatic Aβ42-Induced Pathways to Alzheimer's Disease Pathology.
    Schedin-Weiss S; Nilsson P; Sandebring-Matton A; Axenhus M; Sekiguchi M; Saito T; Winblad B; Saido T; Tjernberg LO
    J Alzheimers Dis; 2020; 75(1):321-335. PubMed ID: 32280097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
    Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
    J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presynaptic failure in Alzheimer's disease.
    Barthet G; Mulle C
    Prog Neurobiol; 2020 Nov; 194():101801. PubMed ID: 32428558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.
    Crews L; Rockenstein E; Masliah E
    Brain Struct Funct; 2010 Mar; 214(2-3):111-26. PubMed ID: 20091183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction.
    Oddo S; Caccamo A; Shepherd JD; Murphy MP; Golde TE; Kayed R; Metherate R; Mattson MP; Akbari Y; LaFerla FM
    Neuron; 2003 Jul; 39(3):409-21. PubMed ID: 12895417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfunction of Neuromuscular Synapses in the Genetic Model of Alzheimer's Disease.
    Mukhamedyarov MA; Grigor'ev PN; Ushanova EA; Zefirov TL; Leushina AV; Zefirov AL
    Bull Exp Biol Med; 2018 Sep; 165(5):669-673. PubMed ID: 30255242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased mtDNA mutations with aging promotes amyloid accumulation and brain atrophy in the APP/Ld transgenic mouse model of Alzheimer's disease.
    Kukreja L; Kujoth GC; Prolla TA; Van Leuven F; Vassar R
    Mol Neurodegener; 2014 May; 9():16. PubMed ID: 24885175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An age-related axon terminal pathology around the first olfactory relay that involves amyloidogenic protein overexpression without plaque formation.
    Cai Y; Xue ZQ; Zhang XM; Li MB; Wang H; Luo XG; Cai H; Yan XX
    Neuroscience; 2012 Jul; 215():160-73. PubMed ID: 22542680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
    Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
    J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.